Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis
Objective: To estimate antiretroviral therapy (ART) adherence rates during pregnancy and
postpartum in high-income, middle-income, and low-income countries. Design: Systematic …
postpartum in high-income, middle-income, and low-income countries. Design: Systematic …
COVID-19: impact on the HIV and tuberculosis response, service delivery, and research in South Africa
Q Abdool Karim, C Baxter - Current HIV/AIDS Reports, 2022 - Springer
Abstract Purpose of Review To describe how mitigation measures against COVID-19 have
impacted HIV and TB research in South Africa. Recent Findings South Africa has the highest …
impacted HIV and TB research in South Africa. Recent Findings South Africa has the highest …
Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure
JR Castillo-Mancilla, JH Zheng, JE Rower… - AIDS research and …, 2013 - liebertpub.com
Tenofovir (TFV) disoproxil fumarate (TDF)±emtricitabine (FTC) are widely used for HIV
treatment and chemoprophylaxis, but variable adherence may lead to suboptimal …
treatment and chemoprophylaxis, but variable adherence may lead to suboptimal …
Measuring, analyzing, and managing drug adherence in resistant hypertension
M Burnier, G Wuerzner, H Struijker-Boudier… - …, 2013 - Am Heart Assoc
One of the main reasons why drug adherence remains generally ignored, outside of clinical
trials and prospective surveys, is the lack of reliable, easy to use, and economical methods …
trials and prospective surveys, is the lack of reliable, easy to use, and economical methods …
COVID-19 affects HIV and tuberculosis care
Q Abdool Karim, SS Abdool Karim - Science, 2020 - science.org
Shortly after instituting coronavirus disease 2019 (COVID-19) mitigation measures, such as
banning air travel and closing schools, the South African government implemented a …
banning air travel and closing schools, the South African government implemented a …
Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat …
Background Simplified regimens with reduced pill burden and fewer side-effects are
desirable for people living with HIV. We investigated the efficacy and safety of switching to a …
desirable for people living with HIV. We investigated the efficacy and safety of switching to a …
A week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients
Objectives: To investigate efficacy and safety of a single-tablet regimen of
darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 800/150/200/10 mg vs …
darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 800/150/200/10 mg vs …
Project Khanya: results from a pilot randomized type 1 hybrid effectiveness‐implementation trial of a peer‐delivered behavioural intervention for ART adherence and …
Abstract Introduction South Africa (SA) has the highest number of people living with HIV
(PLWH) globally, and a significant burden of alcohol and other drug use (AOD). Although …
(PLWH) globally, and a significant burden of alcohol and other drug use (AOD). Although …
Interventions to improve antiretroviral therapy adherence among adolescents and youth in low-and middle-income countries: a systematic review 2015–2019
LK Reif, EJ Abrams, S Arpadi, B Elul, ML McNairy… - AIDS and Behavior, 2020 - Springer
Adolescents and youth living with HIV have poorer antiretroviral treatment (ART) adherence
and viral suppression outcomes than all other age groups. Effective interventions promoting …
and viral suppression outcomes than all other age groups. Effective interventions promoting …
Patient-reported outcomes through 1 year of an HIV-1 clinical trial evaluating long-acting cabotegravir and rilpivirine administered every 4 or 8 weeks (ATLAS-2M)
V Chounta, ET Overton, A Mills, S Swindells… - The Patient-Patient …, 2021 - Springer
Background Advances in HIV-1 therapeutics have led to the development of a range of daily
oral treatment regimens, which share similar high efficacy rates. Consequently, more …
oral treatment regimens, which share similar high efficacy rates. Consequently, more …